START | Midwest

Futó vizsgálatok

• Toboroz

  JUR-003 in Adult Patients With Metastatic Prostate Cancer

  NCT07824349· 1. fázis· Forrás

• Toboroz

  A Study of CHM-029 in Participants With NPM1 Mutated, KMT2A or NUP98 Rearranged AML

  NCT07751991· 1. fázis· Forrás

• Toboroz

  Study of ORM-1153 in Acute Myeloid Leukemia (AML) With CD123 Expression

  NCT07809906· 1. fázis· Forrás

• Toboroz

  A Study of JNJ-98768111 in Participants With Advanced Prostate Cancer

  NCT07746713· 1. fázis· Forrás

• Még nem toboroz

  Phase I Open-Label Randomized Multicenter Study of XNW28012 Monotherapy in Metastatic Pancreatic Cancer

  NCT07707674· 1. fázis· Forrás

• Toboroz

  A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Colorectal Cancer

  NCT07659795· 2. fázis· Forrás

• Toboroz

  DBC-664 in Adult Patients With Solid Tumors

  NCT07705035· 1. fázis· Forrás

• Toboroz

  Phase 1 Study of a Self-amplifying RNA Vaccine (ITI-5000) in Stage 2-3 Triple Negative Breast Cancer

  NCT07652242· 1. fázis· Forrás

• Toboroz

  A Study in Patients With Metastatic Castration-Resistant Prostate Cancer

  NCT07719361· 1. fázis· Forrás

• Toboroz

  A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Pancreatic Cancer

  NCT07644559· 2. fázis· Forrás

• Toboroz

  A Study of ASP546C in Adults With Gastroesophageal Cancer, Pancreatic Cancer or Other Solid Tumors

  NCT07488676· 1/2. fázis· Forrás

• Toboroz

  AVA6103 in Subjects With Locally Advanced or Metastatic Selected Solid Tumors

  NCT07454642· 1. fázis· Forrás

• Toboroz

  A Study of APG-3288 in Relapsed/Refractory Blood Cancers

  NCT07424833· 1. fázis· Forrás

• Toboroz

  A Study to Evaluate the Efficacy of Cemsidomide + Dexamethasone in Participants With Relapsed/Refractory Multiple Myeloma

  NCT07284758· 2. fázis· Forrás

• Toboroz

  A Study to Learn About the Effects of Cemsidomide in Combination With Elranatamab in Relapsed/Refractory Multiple Myeloma Subjects

  NCT07280013· 1. fázis· Forrás

• Toboroz

  A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Anti-tumor Activity of CBI-1214 T Cell Engager in Participants With Advanced or Metastatic MSS/MSI-L Colorectal Cancer

  NCT07321106· 1. fázis· Forrás

• Toboroz

  Study of RMC-5127 in Patients With Advanced KRAS G12V-Mutant Solid Tumors

  NCT07349537· 1. fázis· Forrás

• Toboroz

  A Study of a Selective ERBB2 Inhibitor (CGT4255), in Patients With Advanced Solid Tumors

  NCT07361562· 1. fázis· Forrás

• Toboroz

  Study Evaluating the Safety and Efficacy of HWK-007, a PTK7-directed Antibody Drug Conjugate in Participants With Advanced Solid Tumors

  NCT07444814· 1. fázis· Forrás

• Meghívásos bevonás

  A Phase 1/1b of RNDO-564 Single Agent or in Combination With Pembrolizumab in Bladder Cancer and Other Solid Tumors Associated With Nectin-4

  NCT07218003· 1. fázis· Forrás

• Toboroz

  A Study Evaluating the Safety, Efficacy, and Pharmacokinetics (PK) of EVOLVE104 in Participants With Advanced Urothelial and Squamous Cell Carcinomas

  NCT07217171· 1. fázis· Forrás

• Toboroz

  A Study of ZW251 in Participants With Advanced Solid Tumors

  NCT07164313· 1. fázis· Forrás

• Toboroz

  A Study of IDE849 in Patients With DLL3 Expressing Tumors Including Small Cell Lung Cancer

  NCT07174583· 1/2. fázis· Forrás

• Toboroz

  Phase 1/2 Dose Finding, Safety and PK Study in Advanced Refractory Solid Tumors

  NCT07145255· 1/2. fázis· Forrás

• Toboroz

  Study of CP-383 in Patients With Advanced or Metastatic Solid Tumors

  NCT07030257· 1/2. fázis· Forrás

• Toboroz

  A Study to Find a Suitable Dose of ASP5834 in Adults With Solid Tumors

  NCT07094204· 1. fázis· Forrás

• Toboroz

  A Clinical Study to Test if an Investigational Treatment Called BNT314 When Used in Combination With Another Investigational Treatment Pumitamig (BNT327) and Chemotherapy, is Beneficial and Safe for Patients With Advanced Colorectal Cancer

  NCT07079631· 1/2. fázis· Forrás

• Toboroz

  A Study to Assess the Safety, Tolerability, and Antileukemic Activity of Debio 1562M in Participants With Acute Myeloid Leukemia (AML)

  NCT06969430· 1/2. fázis· Forrás

• Toboroz

  STC-15 as a Part of Combination Therapy With Toripalimab in Selected Advanced Cancers and as Monotherapy in Participants With Selected Sarcomas

  NCT06975293· 1/2. fázis· Forrás

• Toboroz

  A Study of Lorigerlimab in Participants With Advanced Solid Tumors

  NCT06730347· 2. fázis· Forrás

• Toboroz

  A Study of MT-4561 in Patients With Various Advanced Solid Tumors

  NCT06943521· 1/2. fázis· Forrás

• Toboroz

  A Study of mRNA-4106 or mRNA-4200 Administered Alone or in Combination With Anti-Cancer Agents in Participants With Solid Tumors

  NCT06880549· 1. fázis· Forrás

• Toboroz

  A Study of PRMT5 Inhibitor BAY 3713372 in Participants With MTAP-deleted Solid Tumors

  NCT06914128· 1/2. fázis· Forrás

• Toboroz

  A Phase 1 Study of UB-VV111 With and Without Rapamycin in Relapsed/Refractory CD19+ B-cell Malignancies

  NCT06528301· 1. fázis· Forrás

• Toboroz

  A Study to Investigate the Safety and Efficacy of KQB365 as Monotherapy and in Combination in Participants With Advanced Solid Malignancies

  NCT06720987· 1. fázis· Forrás

• Toboroz

  Safety and Preliminary Effectiveness of BNT317, an Investigational Therapy for Advanced Solid Tumors

  NCT06750185· 1/2. fázis· Forrás

• Toboroz

  Phase 1 Study of OP-3136 in Advanced or Metastatic Solid Tumors

  NCT06784193· 1. fázis· Forrás

• Toboroz

  A Study of JNJ-89402638 for Metastatic Colorectal and Gastric Cancers

  NCT06663319· 1. fázis· Forrás

• Toboroz

  Study to Assess Safety and Tolerability of OPN-6602 in Subjects With Relapsed and/or Refractory Multiple Myeloma

  NCT06433947· 1. fázis· Forrás

• Fut, nem toboroz

  Safety/Efficacy Study of CID-078 in Patients With Advanced Solid Tumor Malignancies

  NCT06577987· 1. fázis· Forrás

• Fut, nem toboroz

  A Study to Learn About the Study Medicine PF-07934040 When Given Alone or With Other Anti-cancer Therapies in People With Advanced Solid Tumors That Have a Genetic Mutation.

  NCT06447662· 1. fázis· Forrás

• Toboroz

  A Study of MGC026 in Participants With Advanced Solid Tumors

  NCT06242470· 1. fázis· Forrás

• Fut, nem toboroz

  A Study to Learn About Vepdegestrant When Given With PF-07220060 to People With Advanced or Metastatic Breast Cancer.

  NCT06206837· 1/2. fázis· Forrás

• Toboroz

  A Study of CUSP06 in Patients With Platinum-Refractory/Resistant Ovarian Cancer and Other Advanced Solid Tumors

  NCT06234423· 1. fázis· Forrás

• Toboroz

  A Study to Evaluate the Safety, Pharmacokinetics, and Anti-Tumor Activity of VVD-133214 as Monotherapy and in Combination in Participants With Advanced Solid Tumors

  NCT06004245· 1. fázis· Forrás

• Toboroz

  A Study of JNJ-88549968 for the Treatment of Calreticulin (CALR)-Mutated Myeloproliferative Neoplasms

  NCT06150157· 1. fázis· Forrás

• Toboroz

  A Study of SGN-CEACAM5C in Adults With Advanced Solid Tumors

  NCT06131840· 1. fázis· Forrás

• Toboroz

  Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors

  NCT06128551· 1/2. fázis· Forrás

• Toboroz

  A Phase I/II Study of VLS-1488 in Subjects With Advanced Cancer

  NCT05902988· 1/2. fázis· Forrás

• Fut, nem toboroz

  A Study of ADRX-0706 in Select Advanced Solid Tumors

  NCT06036121· 1. fázis· Forrás

Egyszerre toboroz

Hány vizsgálat toboroz itt egyszerre ugyanarra az indikációra. Darabszám, nem értékelés.

• Tüdőrák24 toboroz
• Vastagbélrák16 toboroz
• Hasnyálmirigyrák14 toboroz
• Petefészekrák11 toboroz
• Prosztatarák9 toboroz
• Gyomor- és nyelőcsőrák8 toboroz
• Hólyagrák7 toboroz
• Méhtestrák7 toboroz
• Fej-nyaki daganatok5 toboroz
• Méhnyakrák5 toboroz
• Máj- és epeúti rák4 toboroz
• Szarkóma4 toboroz
• Tripla negatív emlőrák4 toboroz
• Akut mieloid leukémia (AML)3 toboroz
• Áttétes emlőrák3 toboroz
• Melanóma3 toboroz
• Mielóma multiplex3 toboroz
• Vesedaganat3 toboroz
• Krónikus limfoid leukémia (CLL)2 toboroz
• Neuroendokrin daganatok2 toboroz
• Diffúz nagy B-sejtes limfóma (DLBCL)1 toboroz
• Follikuláris limfóma1 toboroz
• Glioblasztóma1 toboroz
• Gyermekkori daganatok1 toboroz
• Köpenysejtes limfóma1 toboroz
• Mezotelióma1 toboroz
• Mieloproliferatív neopláziák1 toboroz

Kutatók

Ide még nem kötődik kutató.

Lezárt vizsgálatok

• Leállították

  A Clinical Trial of PF-08046037 Alone or With Sasanlimab in Patients With Advanced or Metastatic Malignancies

  NCT06974734· 1. fázis· Forrás

• Leállították

  A Study to Learn About PF-07921585 Alone or With Other Anti-cancer Medicines in People With Cancer

  NCT06580938· 1. fázis· Forrás

• Leállították

  A Study to Learn About How Different Amounts of the Study Medicine PF-07826390 Act in the Body of People With Cancer When Taken Alone or With Other Anti-cancer Medicines.

  NCT06546553· 1. fázis· Forrás

• Leállították

  A Study to Find a Suitable Dose of ASP4396 in Adults With Solid Tumors

  NCT06364696· 1. fázis· Forrás

• Leállították

  A Study of PF-07820435 as a Single Agent and in Combination in Participants With Advanced Solid Tumors

  NCT06285097· 1. fázis· Forrás

• Leállították

  Study of IK-595 in RAS- or RAF-altered Advanced Tumors

  NCT06270082· 1. fázis· Forrás

• Leállították

  Study of EO-3021 in Adult Patients With Solid Tumors Likely to Express CLDN18.2

  NCT05980416· 1. fázis· Forrás

• Leállították

  Study of the CHK1 Inhibitor BBI-355, an ecDNA-directed Therapy (ecDTx), and the RNR Inhibitor BBI-825, in Subjects With Tumors With Oncogene Amplifications

  NCT05827614· 1. fázis· Forrás

• Leállították

  Safety, Tolerability, PK/PD & Preliminary Efficacy of SKL27969 in Advanced Solid Tumors Patients

  NCT05388435· 1/2. fázis· Forrás

• Lezárult

  Phase 1b Study of SL-172154 Administered With Combination Agent(s) in Subjects With Ovarian Cancers

  NCT05483933· 1. fázis· Forrás

• Toboroz

  A Study of Amivantamab Monotherapy and in Addition to Standard-of-Care Chemotherapy in Participants With Advanced or Metastatic Colorectal Cancer

  NCT05379595· 1/2. fázis· Forrás

• Leállították

  A Study of SGN-ALPV in Advanced Solid Tumors

  NCT05229900· 1. fázis· Forrás

• Leállították

  A Study to Evaluate KIN-3248 in Participants With Advanced Tumors Harboring FGFR2 and//or FGFR3 Gene Alterations

  NCT05242822· 1. fázis· Forrás

• Leállították

  Phase 1 Study of Shattuck Labs (SL)-172154 in Subjects With MDS or AML

  NCT05275439· 1. fázis· Forrás

• Lezárult

  Glycan Mediated Immune Regulation With a Bi-Sialidase Fusion Protein (GLIMMER-01)

  NCT05259696· 1/2. fázis· Forrás

• Leállították

  Oral TEAD Inhibitor Targeting the Hippo Pathway in Subjects with Advanced Solid Tumors

  NCT05228015· 1. fázis· Forrás

• Lezárult

  S095029 as Monotherapy and in Combination With Sym021 in Patients With Advanced Solid Tumor Malignancies Followed by an Expansion Part With Triple Combinations in Patients With Metastatic Gastric or Colorectal Cancers

  NCT05162755· 1. fázis· Forrás

• Lezárult

  INCB000928 Administered as a Monotherapy or in Combination With Ruxolitinib in Participants With Anemia Due to Myeloproliferative Disorders

  NCT04455841· 1/2. fázis· Forrás

• Leállították

  PF-07284892 in Participants With Advanced Solid Tumors

  NCT04800822· 1. fázis· Forrás

• Lezárult

  Sym024 Monotherapy and in Combination With Sym021 in Patients With Advanced Solid Tumor Malignancies

  NCT04672434· 1. fázis· Forrás

• Lezárult

  Sym021 in Combination With Either Sym022 or Sym023 or Sym023 and Irinotecan in Patients With Recurrent Advanced Selected Solid Tumor Malignancies

  NCT04641871· 1. fázis· Forrás

• Lezárult

  COM701 in Combination With BMS-986207 and Nivolumab in Subjects With Advanced Solid Tumors.

  NCT04570839· 1/2. fázis· Forrás

• Lezárult

  Phase 1a/1b Study of TPST-1495 as a Single Agent and in Combination With Pembrolizumab in Subjects With Solid Tumors

  NCT04344795· 1. fázis· Forrás

• Lezárult

  COM902 (A TIGIT Inhibitor) in Subjects With Advanced Malignancies

  NCT04354246· 1. fázis· Forrás

• Leállították

  A First-in-human Study Using BDC-1001 as a Single Agent and in Combination With Nivolumab in Advanced HER2-Expressing Solid Tumors

  NCT04278144· 1/2. fázis· Forrás

• Leállították

  Study to Test the Safety and Tolerability of PF-07062119 in Patients With Selected Advanced or Metastatic Gastrointestinal Tumors.

  NCT04171141· 1. fázis· Forrás

• Leállították

  Study of INBRX-105 and INBRX-105 With Pembrolizumab in Patients With Solid Tumors Including Head and Neck Cancer

  NCT03809624· 1. fázis· Forrás

• Lezárult

  MGD019 DART® Protein in Unresectable/Metastatic Cancer

  NCT03761017· 1. fázis· Forrás

• Lezárult

  COM701 (an Inhibitor of PVRIG) in Subjects With Advanced Solid Tumors.

  NCT03667716· 1. fázis· Forrás